Cite
Dyson G, Farran B, Bolton S, et al. The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer. Am J Cancer Res. 2018;8(10):2088-2095
Dyson, G., Farran, B., Bolton, S., Craig, D. B., Dombkowski, A., Beebe-Dimmer, J. L., Powell, I. J., Podgorski, I., Heilbrun, L. K., & Bock, C. H. (2018). The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer. American journal of cancer research, 8(10), 2088-2095.
Dyson, Greg, et al. "The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer." American journal of cancer research vol. 8,10 (2018): 2088-2095.
Dyson G, Farran B, Bolton S, Craig DB, Dombkowski A, Beebe-Dimmer JL, Powell IJ, Podgorski I, Heilbrun LK, Bock CH. The extrema of circulating miR-17 are identified as biomarkers for aggressive prostate cancer. Am J Cancer Res. 2018 Oct 01;8(10):2088-2095. eCollection 2018. PMID: 30416858; PMCID: PMC6220145.
Copy
Download .nbib